A Prospective, Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
CompletedOBSERVATIONAL
Enrollment
100
Participants
Timeline
Start Date
April 18, 2013
Primary Completion Date
January 25, 2017
Study Completion Date
January 25, 2017
Conditions
Rheumatoid Arthritis
Trial Locations (12)
652
Saida
961
Beirut
1401
Byblos
3050
Doha
13041
Safat
99999
Beirut
11-236
Beirut
470 Hazmieh
Beirut
Unknown
Beirut
371 Tripoli
Tripoli
P.O. Box 31500
Dubai
P.O. Box 8179
Dubai
All Listed Sponsors
lead
Hoffmann-La Roche
INDUSTRY
NCT01770834 - A Prospective, Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter